{"transactions":[{"id":1548860,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-03T20:00:27.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2025."}],"balance_after":32000,"derivative":{"exercise_price":7.73,"expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001104659-24-043247","document":"tm2410652-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465924043247/tm2410652-6_4seq1.xml","form_type":"4"}},{"id":1584399,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-11T23:34:28.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":146000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":146000,"derivative":{"exercise_price":5.32,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":146000},"source":{"system":"sec-edgar","filing":"0001062993-24-006181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324006181/form4.xml","form_type":"4"}},{"id":1584398,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2024-03-11T23:34:28.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the \"Company's\") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001062993-24-006181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324006181/form4.xml","form_type":"4"}},{"id":1919683,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T23:56:44.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on April 12, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":131250,"derivative":{"exercise_price":2.91,"expiration_date":"2033-04-12","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001062993-23-009200","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323009200/form4.xml","form_type":"4"}},{"id":1927106,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-04T20:03:28.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":25200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2024."}],"balance_after":25200,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":25200},"source":{"system":"sec-edgar","filing":"0001104659-23-041731","document":"tm2311410-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465923041731/tm2311410-11_4seq1.xml","form_type":"4"}},{"id":2303753,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-05T16:08:32.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2023."}],"balance_after":16500,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-22-042748","document":"tm2211665-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465922042748/tm2211665-14_4seq1.xml","form_type":"4"}},{"id":2424109,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-27T21:50:24.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":105000,"derivative":{"exercise_price":13.15,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001062993-22-001687","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322001687/form4.xml","form_type":"4"}},{"id":2757117,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-05T20:15:46.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2022."}],"balance_after":16500,"derivative":{"exercise_price":31.58,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-21-046725","document":"tm2112099-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465921046725/tm2112099-7_4seq1.xml","form_type":"4"}},{"id":3185887,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-02T16:32:18.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2021."}],"balance_after":16500,"derivative":{"exercise_price":9.78,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-20-042502","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465920042502/a4.xml","form_type":"4"}},{"id":3563951,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-03T17:27:09.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2020."}],"balance_after":13500,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-19-019715","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465919019715/a4.xml","form_type":"4"}},{"id":3860711,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T17:23:48.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 24 equal monthly installments thereafter."}],"balance_after":27000,"derivative":{"exercise_price":15,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001104659-18-047454","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000110465918047454/a4.xml","form_type":"4"}},{"id":4459222,"issuer":{"id":168572,"kind":"organization","name":"Juno Therapeutics, Inc.","symbol":"JUNO"},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-09T19:36:14.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":68182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vests and becomes exercisable on March 7, 2017 and 1/48th of the shares subject to the option vests and becomes exercisable monthly thereafter."}],"balance_after":68182,"derivative":{"exercise_price":20.76,"expiration_date":"2027-02-06","underlying":"Common Stock","underlying_shares":68182},"source":{"system":"sec-edgar","filing":"0001209191-17-009299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000120919117009299/doc4.xml","form_type":"4"}},{"id":4459221,"issuer":{"id":168572,"kind":"organization","name":"Juno Therapeutics, Inc.","symbol":"JUNO"},"owners":[{"id":92252,"kind":"person","name":"Levitsky Hyam","position":1,"cik":"0001375792","reported_name":"Levitsky Hyam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & CSO"}}],"security":"Common Stock","published_at":"2017-02-09T19:36:14.000Z","date":"2017-02-07","kind":"grant","acquired":true,"shares":14634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the 2014 Equity Incentive Plan. 25% of the RSUs vest on each anniversary of February 7, 2017."}],"balance_after":131334,"source":{"system":"sec-edgar","filing":"0001209191-17-009299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375792/000120919117009299/doc4.xml","form_type":"4"}}]}